Forecast: Import of Vaccines for Human Use to Switzerland

The import of vaccines for human use to Switzerland is set to follow a steady growth trajectory from 2024 to 2028. Starting at 130.29 thousand kilograms in 2024, the volume is forecasted to increase annually to reach 140.39 thousand kilograms by 2028. Based on the actual data recorded in 2023, this marks a consistent upward trend over the forecasted years.

Year-on-year variations show a gradual increase:

• 2024 to 2025: +2.0%
• 2025 to 2026: +1.9%
• 2026 to 2027: +1.8%
• 2027 to 2028: +1.8%

Over the last two years, the trend demonstrates sustained growth with an average CAGR of roughly 1.9% per year.

Future trends to watch for include potential market disruptions due to geopolitical events, advancements in vaccine technology, and evolving public health policies. The impact of global health initiatives and partnerships may also alter the demand and supply dynamics for vaccines imported into Switzerland.